A phase Ib/II study of fruquintinib in combination with paclitaxel as the second-line therapy for advanced gastric cancer.
作者信息
Zhang Yang, Wang Zi-Xian, Shen Lin, Li Jin, Huang Jing, Su Wei-Guo, Zhang Dong-Sheng, Xu Rui-Hua
机构信息
Department of Clinical Research, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China.
Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
出版信息
Cancer Commun (Lond). 2023 Jan;43(1):150-153. doi: 10.1002/cac2.12379. Epub 2022 Nov 4.
Abstract
摘要
Zotero 插件